The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model
Main Authors: | , , , , , , |
---|---|
Other Authors: | |
Format: | Conference item |
Language: | English |
Published: |
Elsevier
2020
|
_version_ | 1826286842997112832 |
---|---|
author | Krendyukov, A Kneisel, N Zhu, J Merz, C Richards, D Gieffers, C Van Den Eynde, B |
author2 | Mitchell, T |
author_facet | Mitchell, T Krendyukov, A Kneisel, N Zhu, J Merz, C Richards, D Gieffers, C Van Den Eynde, B |
author_sort | Krendyukov, A |
collection | OXFORD |
description | |
first_indexed | 2024-03-07T01:49:43Z |
format | Conference item |
id | oxford-uuid:99a872a5-16de-42a4-be85-4b7000f9a09f |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-07T01:49:43Z |
publishDate | 2020 |
publisher | Elsevier |
record_format | dspace |
spelling | oxford-uuid:99a872a5-16de-42a4-be85-4b7000f9a09f2022-03-27T00:15:56ZThe role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP modelConference itemhttp://purl.org/coar/resource_type/c_c94fuuid:99a872a5-16de-42a4-be85-4b7000f9a09fEnglishSymplectic ElementsElsevier2020Krendyukov, AKneisel, NZhu, JMerz, CRichards, DGieffers, CVan Den Eynde, BMitchell, T |
spellingShingle | Krendyukov, A Kneisel, N Zhu, J Merz, C Richards, D Gieffers, C Van Den Eynde, B The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model |
title | The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model |
title_full | The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model |
title_fullStr | The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model |
title_full_unstemmed | The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model |
title_short | The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model |
title_sort | role of asunercept as a selective cd95l inhibitor in cutaneous melanoma rationale and results from an enhanced tirp model |
work_keys_str_mv | AT krendyukova theroleofasunerceptasaselectivecd95linhibitorincutaneousmelanomarationaleandresultsfromanenhancedtirpmodel AT kneiseln theroleofasunerceptasaselectivecd95linhibitorincutaneousmelanomarationaleandresultsfromanenhancedtirpmodel AT zhuj theroleofasunerceptasaselectivecd95linhibitorincutaneousmelanomarationaleandresultsfromanenhancedtirpmodel AT merzc theroleofasunerceptasaselectivecd95linhibitorincutaneousmelanomarationaleandresultsfromanenhancedtirpmodel AT richardsd theroleofasunerceptasaselectivecd95linhibitorincutaneousmelanomarationaleandresultsfromanenhancedtirpmodel AT gieffersc theroleofasunerceptasaselectivecd95linhibitorincutaneousmelanomarationaleandresultsfromanenhancedtirpmodel AT vandeneyndeb theroleofasunerceptasaselectivecd95linhibitorincutaneousmelanomarationaleandresultsfromanenhancedtirpmodel AT krendyukova roleofasunerceptasaselectivecd95linhibitorincutaneousmelanomarationaleandresultsfromanenhancedtirpmodel AT kneiseln roleofasunerceptasaselectivecd95linhibitorincutaneousmelanomarationaleandresultsfromanenhancedtirpmodel AT zhuj roleofasunerceptasaselectivecd95linhibitorincutaneousmelanomarationaleandresultsfromanenhancedtirpmodel AT merzc roleofasunerceptasaselectivecd95linhibitorincutaneousmelanomarationaleandresultsfromanenhancedtirpmodel AT richardsd roleofasunerceptasaselectivecd95linhibitorincutaneousmelanomarationaleandresultsfromanenhancedtirpmodel AT gieffersc roleofasunerceptasaselectivecd95linhibitorincutaneousmelanomarationaleandresultsfromanenhancedtirpmodel AT vandeneyndeb roleofasunerceptasaselectivecd95linhibitorincutaneousmelanomarationaleandresultsfromanenhancedtirpmodel |